Honig, L.S., B. Vellas, M. Woodward, M. Boada, R. Bullock, M. Borrie, et al. 2018. Trial of solanezumab for mild dementia due to Alzheimer’s disease. New England Journal of Medicine 378: 321–330. https://doi.org/10.1056/NEJMOA1705971.

CAS  Article  PubMed  Google Scholar 

Yamazaki, Y., N. Zhao, T.R. Caulfield, C.C. Liu, and G. Bu. 2019. Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies. Nature Reviews. Neurology 15: 501–518. https://doi.org/10.1038/S41582-019-0228-7.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Querfurth, H.W., and F.M. LaFerla. 2010. Alzheimer’s disease. New England Journal of Medicine 362: 329–344. https://doi.org/10.1056/NEJMRA0909142.

CAS  Article  PubMed  Google Scholar 

Stephenson, J., E. Nutma, P. van der Valk, and S. Amor. 2018. Inflammation in CNS neurodegenerative diseases. Immunology 154: 204–219. https://doi.org/10.1111/IMM.12922.

CAS  Article  PubMed  Google Scholar 

Lamkanfi, M., and V.M. Dixit. 2009. Inflammasomes: Guardians of cytosolic sanctity. Immunological Reviews 227: 95–105. https://doi.org/10.1111/J.1600-065X.2008.00730.X.

CAS  Article  PubMed  Google Scholar 

Heneka, M.T., M.P. Kummer, A. Stutz, A. Delekate, S. Schwartz, A. Vieira-Saecker, et al. 2013. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493: 674–678. https://doi.org/10.1038/NATURE11729.

CAS  Article  PubMed  Google Scholar 

Lamkanfi, M., and V.M. Dixit. 2014. Mechanisms and functions of inflammasomes. Cell 157: 1013–1022. https://doi.org/10.1016/J.CELL.2014.04.007.

CAS  Article  PubMed  Google Scholar 

Halle, A., V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, T. Reinheckel, et al. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nature Immunology 9: 857–865. https://doi.org/10.1038/NI.1636.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Meyer-Luehmann, M., T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. De Calignon, A. Rozkalne, et al. 2008. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease. Nature 451: 720–724. https://doi.org/10.1038/NATURE06616.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Pétrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death and Differentiation 14: 1583–1589. https://doi.org/10.1038/SJ.CDD.4402195.

Article  PubMed  Google Scholar 

Savage, C. D., G. Lopez-Castejon, A. Denes, and D. Brough 2012. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Frontiers Immunology 3. https://doi.org/10.3389/FIMMU.2012.00288/FULL.

Suzuki, T., K. Kohyama, K. Moriyama, M. Ozaki, S. Hasegawa, T. Ueno, et al. 2020. Extracellular ADP augments microglial inflammasome and NF-κB activation via the P2Y12 receptor. European Journal of Immunology 50: 205–219. https://doi.org/10.1002/EJI.201848013.

CAS  Article  PubMed  Google Scholar 

Zhou, R., A. Tardivel, B. Thorens, I. Choi, and J. Tschopp. 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 11: 136–140. https://doi.org/10.1038/NI.1831.

CAS  Article  PubMed  Google Scholar 

Murphy, N., T.R. Cowley, J.C. Richardson, D. Virley, N. Upton, D. Walter, et al. 2012. The neuroprotective effect of a specific P2X7 receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells. Brain Pathology 22: 295–306. https://doi.org/10.1111/J.1750-3639.2011.00531.X.

CAS  Article  PubMed  Google Scholar 

Wu, A., X. Zhou, G. Qiao, L. Yu, Y. Tang, and L. Yan. 2021. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Elsevier 2147:101–2.

Bai, H., Q.F. Zhang, J.J. Duan, D.J. Yu, and L.J. Liu. 2018. Downregulation of signal transduction and STAT3 expression exacerbates oxidative stress mediated by NLRP3 inflammasome. Neural Regeneration Research 13: 2147. https://doi.org/10.4103/1673-5374.241470.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sharma, D., and T.D. Kanneganti. 2016. The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. Journal of Cell Biology 213: 617–629. https://doi.org/10.1083/JCB.201602089.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gold, M., and J. El Khoury. 2015. β-amyloid, microglia, and the inflammasome in Alzheimer’s disease. Semin Immunopathol 37: 607–611. https://doi.org/10.1007/S00281-015-0518-0.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Scambler, T., H.H. Jarosz-Griffiths, S. Lara-Reyna, S. Pathak, J. Wong, J. Holbrook, et al. 2019. ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis. Elife 8. https://doi.org/10.7554/ELIFE.49248.

Shimada, K., T. Crother, J. Karlin, and J. Dagvadorj. 2012. Immunity NC-, 2012 undefined. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Elsevier n.d.

Wu, P.J., Y.F. Hung, H.Y. Liu, and Y.P. Hsueh. 2017. Deletion of the inflammasome sensor Aim2 mitigates Aβ deposition and microglial activation but increases inflammatory cytokine expression in an Alzheimer disease mouse model. NeuroImmunoModulation 24: 29–39. https://doi.org/10.1159/000477092.

CAS  Article  PubMed  Google Scholar 

Lučiūnaitė, A., R.M. Mcmanus, M. Jankunec, I. Rácz, C. Dansokho, I. Dalgėdienė, et al. 2019. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia. Wiley Online Libr 155: 650–661. https://doi.org/10.1111/jnc.14945.

CAS  Article  Google Scholar 

Furman, D., J. Chang, L. Lartigue, C. Bolen. 2017. Medicine FH-N, 2017 U. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. NatureCom.

Friker, L., H. Scheiblich, and I. Hochheiser. 2020. Reports RB-C, 2020 U. β-amyloid clustering around ASC fibrils boosts its toxicity in microglia. Elsevier.

Ahmed, M.E., S. Iyer, R. Thangavel, D. Kempuraj, G.P. Selvakumar, S.P. Raikwar, et al. 2017. Co-localization of glia maturation factor with NLRP3 inflammasome and autophagosome markers in human Alzheimer’s disease brain. J Alzheimer’s Dis 60: 1143–1160. https://doi.org/10.3233/JAD-170634.

CAS  Article  Google Scholar 

Saresella, M., F. La Rosa, F. Piancone, M. Zoppis, I. Marventano, E. Calabrese, et al. 2016. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease. Molecular Neurodegeneration 11: 23–37. https://doi.org/10.1186/S13024-016-0088-1.

Article  PubMed  PubMed Central  Google Scholar 

Marchetti, C., S. Toldo, J. Chojnacki, E. Mezzaroma, K. Liu, F.N. Salloum, et al. 2015. Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse. Journal of Cardiovascular Pharmacology 66: 1–8. https://doi.org/10.1097/FJC.0000000000000247.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Muñoz-Planillo, R., P. Kuffa, G. Martínez-Colón, B.L. Smith, T.M. Rajendiran, and G. Núñez. 2013. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142–1153. https://doi.org/10.1016/J.IMMUNI.2013.05.016.

Article  PubMed  PubMed Central  Google Scholar 

Walev, I., J. Klein, M. Husmann, A. Valeva, S. Strauch, H. Wirtz, et al. 2000. Potassium regulates IL-1 beta processing via calcium-independent phospholipase A2. The Journal of Immunology 164: 5120–5124. https://doi.org/10.4049/JIMMUNOL.164.10.5120.

CAS  Article  PubMed  Google Scholar 

Marchetti, C., J. Chojnacki, S. Toldo, E. Mezzaroma, N. Tranchida, S.W. Rose, et al. 2014. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse. Journal of Cardiovascular Pharmacology 63: 316–322. https://doi.org/10.1097/FJC.0000000000000053.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Nakanishi, A., N. Kaneko, H. Takeda, T. Sawasaki, S. Morikawa, W. Zhou, et al. 2018. Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system. Inflamm Regen 38. https://doi.org/10.1186/S41232-018-0085-6.

Yin, J., F. Zhao, J.E. Chojnacki, J. Fulp, W.L. Klein, S. Zhang, et al. 2018. NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer’s disease. Molecular Neurobiology 55: 1977–1987. https://doi.org/10.1007/S12035-017-0467-9.

CAS  Article  PubMed  Google Scholar 

Fulp, J., L. He, S. Toldo, Y. Jiang, A. Boice, C. Guo, et al. 2018. Structural insights of benzenesulfonamide analogues as NLRP3 inflammasome inhibitors: Design, synthesis, and biological characterization. Journal of Medicinal Chemistry 61: 5412–5423. https://doi.org/10.1021/ACS.JMEDCHEM.8B00733.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Groß, C.J., R. Mishra, K.S. Schneider, G. Médard, J. Wettmarshausen, D.C. Dittlein, et al. 2016. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45: 761–773. https://doi.org/10.1016/J.IMMUNI.2016.08.010.

Article  PubMed  Google Scholar 

Sanman, L.E., Y. Qian, N.A. Eisele, T.M. Ng, W.A. van der Linden, and D.M. Monack, et al. 2016. Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. Elife 5. https://doi.org/10.7554/ELIFE.13663.

Clapham, D.E., 2007. Calcium signaling. Cell 1047–58.

Murakami, T., J. Ockinger, J. Yu, V. Byles, A. McColl, A.M. Hofer, et al. 2012. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109: 11282–11287. https://doi.org/10.1073/PNAS.1117765109/-/DCSUPPLEMENTAL.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lee, G.S., N. Subramanian, A.I. Kim, I. Aksentijevich, R. Goldbach-Mansky, D.B. Sacks, et al. 2012. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nat 492:123–7. https://doi.org/10.1038/nature11588.

Feldmeyer, L., M. Keller, G. Niklaus, D. Hohl, S. Werner, and H.D. Beer. 2007. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Current Biology 17: 1140–1145. https://doi.org/10.1016/J.CUB.2007.05.074.

CAS  Article  PubMed  Google Scholar 

Chu, J., L.M. Thomas, S.C. Watkins, L. Franchi, G. Núñez, and R.D. Salter. 2009. Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. Journal of Leukocyte Biology 86: 1227–1238. https://doi.org/10.1189/JLB.0309164.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Schorn, C., B. Frey, K. Lauber, C. Janko, M. Strysio, H. Keppeler, et al. 2011. Sodium overload and water influx activate the NALP3 inflammasome. Journal of Biological Chemistry 286: 35–41. https://doi.org/10.1074/JBC.M110.139048.

CAS  Article  PubMed  Google Scholar 

Verhoef, P.A., S.B. Kertesy, K. Lundberg, J.M. Kahlenberg, and G.R. Dubyak. 2005. Inhibitory effects of chloride on the ac